Dyne Therapeutics, Inc.
DYN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818794
In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Dyne Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- +12 vs. Q3 2022
- Shares held
- 49.7M
- +5.16M (+11.6%) vs. Q3 2022
- Total value
- $576.2M
- +$10.4M (+1.8%) vs. Q3 2022
- New holders
- 21
- 37 more added
- Sold out
- 9
- 34 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DYN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 245 | $4.23B |
| Q1 2026 | 228 | $3.40B |
| Q4 2025 | 233 | $3.48B |
| Q3 2025 | 207 | $1.97B |
| Q2 2025 | 198 | $1.22B |
| Q1 2025 | 205 | $1.29B |
| Q4 2024 | 200 | $2.63B |
| Q3 2024 | 200 | $4.03B |
| Q2 2024 | 193 | $3.92B |
| Q1 2024 | 169 | $2.71B |
| Q4 2023 | 124 | $930.0M |
| Q3 2023 | 114 | $536.6M |
| Q2 2023 | 118 | $665.9M |
| Q1 2023 | 127 | $628.7M |
| Q4 2022 | 113 | $576.2M |
| Q3 2022 | 102 | $565.8M |
| Q2 2022 | 90 | $320.7M |
| Q1 2022 | 94 | $456.6M |
| Q4 2021 | 93 | $568.3M |
| Q3 2021 | 83 | $572.8M |
| Q2 2021 | 76 | $753.4M |
| Q1 2021 | 75 | $533.3M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Dyne Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 939,648 | $10.9M | 0.23% | −60,352−6.0% | Reduced |
| Point72 Asset Management, L.P. | 1,387,668 | $16.1M | 0.06% | −109,963−7.3% | Reduced |
| Vanguard Group Inc | 1,644,410 | $19.1M | 0.00% | +306,045+22.9% | Added |
| Franklin Resources Inc | 1,778,301 | $20.6M | 0.01% | −4,570−0.3% | Reduced |
| Logos Global Management LP | 2,150,000 | $24.9M | 2.92% | −137,321−6.0% | Reduced |
| Vida Ventures Advisors, LLC | 2,220,034 | $25.7M | 34.58% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 2,322,384 | $26.9M | 0.82% | +2,322,384 | New |
| Wasatch Advisors Inc | 2,519,579 | $29.2M | 0.20% | +227,311+9.9% | Added |
| BlackRock Inc. | 2,618,618 | $30.3M | 0.00% | +93,551+3.7% | Added |
| Deep Track Capital, LP | 2,684,200 | $31.1M | 1.36% | −500,000−15.7% | Reduced |
| Citadel Advisors LLC | 2,910,079 | $33.7M | 0.04% | −12,293−0.4% | Reduced |
| MPM Asset Management LLC | 4,951,303 | $57.4M | 24.01% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114.4M | 13.78% | +934,581+10.5% | Added |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −765,953−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −220,400−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −176,490−100.0% | Sold out |
| Alpha Paradigm Partners, LLC | 0 | $0 | 0.00% | −34,630−100.0% | Sold out |
| Financial Management Network Inc | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −23,601−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −19,705−100.0% | Sold out |
| HC Advisors, LLC | 0 | $0 | 0.00% | −14,272−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| FourThought Financial, LLC | – | – | – | – | Not filed |